nerve block, subarachnoid block, and epidural block off er benefi ts that can be observed as long as 1 year after surgery. [1] [2] [3] [4] Anticonvulsants and tricyclic antidepressants were conventionally used for neuropathic pain. Gabapentin, a structural analogue of gamma-aminobutyric acid (GABA), introduced in 1994 as an antiepileptic drug and later used for chronic pain conditions such as neuropathic pain, [3] diabetic neuropathy, postherpetic neuralgia, complex regional pain syndrome, [4] exerts its eff ects by binding with alpha 2 delta subunit of presynaptic voltage gated Ca 2+ channels [5] and has antinociceptive, antihyperalgesic, and antiallodynic properties. [6] Several studies have shown the eff ectiveness of gabapentin as an agent for acute postoperative pain relief resulting in reduced postoperative analgesic requirement in abdominal hysterectomy, [7] spinal surgery, [8] radical mastectomy, [9] and laparoscopic cholecystectomy. [10] Pregabalin, another analogue of GABA that shares some characteristics with its predecessor gabapentin, however with superior pharmacokinetic profi le, [11] introduced in 2004 already has an established role in the treatment of peripheral neuropathic pain associated with diabetes mellitus and postherpetic neuralgia. On review of the recent literatures, pregabalin showed evidence that it might be effi cacious in relieving acute pain similar to gabapentin [12] [13] [14] although there is a relative paucity of studies comparing them.
In view of the above observations, the present study was designed as randomized, double-blinded, parallel group, open label trial to compare the effi cacy of pregabalin and gabapentin as preemptive analgesics in surgery below the umbilicus under spinal anesthesia.
Materials and Methods
This randomized double-blinded prospective study was conducted in a time span of 1 year in a tertiary care hospital of eastern India after obtaining institutional ethical clearance and informed consent of the subjects.
Inclusion criteria
Patients of both sexes in the age group of 20-50 years having body weight 50-70 kg and with physical status American Society of Anesthesiologists (ASA)-I and ASA-II undergoing infraumbilical surgeries under spinal anesthesia were included.
As calculated from a previous study [14] to get a clinically relevant difference in the duration of postoperative analgesia, we needed 31 patients in each group with a power of study 80% at 95% confidence interval (alpha = 0.05). Total number of patients = 62; they were randomly allocated in two groups using an online randomizer. Group G (n = 31) received a single dose of gabapentin 1,200 mg; Group P (n = 31) received a single dose of pregabalin 300 mg.
Exclusion criteria
Patients with uncontrolled or labile hypertension, allergic to the study drugs, pregnant and lactating women, patients with psychiatric illness, hepatic impairment, or renal impairment, and patients having any contraindication to spinal anesthesia were excluded.
The parameters studied for comparing the quality of intraoperative and postoperative analgesia and sedation:
For pain: a. Visual analogue scale (VAS) [14] between 0 cm and 10 cm; 0 = no pain; 10 = most severe pain b. Time lapsed after operation when the patient needs rescue analgesic for sedation: Filos' numerical scale Scale 1 = awake and nervous Scale 2 = awake and relaxed Scale 3 = sleepy but easy to awake Scale 4 = sleepy and hard to awake
The parameters studied for comparing adverse eff ects: Dizziness/somnolence; diplopia; vomiting [the severity of PONV will be graded on a 4-point ordinal scale; (0 = no nausea/vomiting; 1 = mild nausea; 2 = moderate nausea; 3 = severe nausea with vomiting)]; confusion (assessed by asking time, place, person); urinary retention in a noncatheterized patient; respiratory depression [defi ned as ventilatory frequency <8 bpm and oxygen saturation <90% without oxygen supplementation].
Patients in Group G (n = 31) received a single dose of gabapentin 1,200 mg, whereas in the Group P (n = 31), patients were administered pregabalin 300 mg per oral 1 h prior to the administration of spinal anesthesia. No other premedication was instituted.
A day before the scheduled operation the patients were visited preoperatively in their wards for preanesthetic checkup. A thorough clinical history was obtained. They were physically examined, laboratory investigations were reviewed and details about VAS [14] (0-10 cm) was explained on the day before operation. The patients were also explained about the procedures of spinal anesthesia and postoperative pain relief and all queries and doubts were answered to get their confi dence and support. A pharmacologist of our institution not involved in this study prepared the drug containing bags, each containing four hard gelatin capsules. Ingroup G, the bag contained four 300 mg hard gelatin capsules of gabapentin belonging to one particular pharmaceutical company; in group P the bag contained four 75 mg hard gelatin capsules of pregabalin belonging to the same pharmaceutical company (size and shape looked similar). The medication was given to the patient by an anesthesiologist not involved in the study 1 h before the induction of anesthesia.
Routine monitoring in the form of noninvasive blood pressure amplifi er (NIBP), pulse oximetry, and electrocardiogram (ECG) were instituted on arrival in operation theater. All the patients were preloaded with 10 mL/kg lactated Ringer's solution before being administered spinal anesthesia. Spinal anesthesia was instituted with 3 mL of 0.5% bupivacaine (15 mg) at L 3 -L 4 /L 4 -L 5 level. Fluid administration was continued intraoperatively and hypotension, if any, was treated with fl uid replacement and intravenous (IV) mephentermin, and this whole procedure was conducted by another anesthetist.
Pain was assessed postoperatively by VAS in the immediate postoperative period and every 2 h thereafter, which was explained to the patient during the preoperative visit. When patient was shifted to the ward anesthesiologists, unaware that premedication was responsible for charting the pain score by VAS scale. Pain charting was done separately and anesthetic chart was not attached with the case sheet, so the observer was not able to assess to which group the patient belonged.
Any patient with VAS score of more than 3 received diclofenac 1 mg/kg intramuscularly. Time since spinal anesthesia to the fi rst dose of analgesic and total dose of analgesic in the fi rst 24 h was recorded. Any complications such as dizziness, somnolence, diplopia, vomiting, confusion, respiratory depression, pain, and urinary retention were recorded in the fi rst 24-h postoperative period.
Statistical analysis
The 
Results
Sixty-two patients, of either sex, aged 20-50 years, belonging to ASA grades I and II, and scheduled to undergo infraumblical surgeries were included in this prospective, randomized, double-blinded, parallel group, open label study. All the groups were comparable in respect to demographic data, ASA physical status, the mean duration of surgery, and the type of surgeries performed. Maximum number of participants belonged to the age group of 40 years and above. The male-female ratio was 1:1.38.
In the 24 h of postoperative period, the mean VAS scores at rest of Group P was always signifi cantly lower than those of Group G. The time to fi rst dose of rescue analgesic was compared between the groups. In Group G (gabapentin group), rescue analgesic was given after 9.41 ± 1.84 h while in Group P (pregabalin group) rescue analgesic was required after 15.38 ± 3.52 h. In Group G subsequent rescue analgesic was required in only three cases while in Group P, subsequent rescue analgesic was required in only two cases.
In the pregabalin group, the incidence of somnolence (12.90%) and dizziness (9.68%) were signifi cantly less than the other group (gabapentin group -22.59% and 19.35%, respectively) while the incidences of nausea and vomiting were absent in both the groups. The groups did not vary with respect to the average time required for the surgical maneuver as shown in Table 1 .
The study groups had a signifi cant variation in the time interval after surgery when the VAS score was found to be 3 or more signaling the need of rescue analgesic. In Group P, the time interval was more compared to Group G as shown in Table 2 . The time required for the administration of the rescue analgesic postoperatively was found to be significantly earlier in case of Group G compared to Group P. That means that pregabalin showed prolonged postoperative analgesia compared to gabapentin [ Table 3 ].
Discussion
Management of pain and its complications in the postoperative period still is a major challenge. Preemptive analgesia is a treatment that prevents establishment of the altered sensory processing that amplifi es postoperative pain. Preincisional analgesia has been shown to be more eff ective in the control of postoperative pain by protecting the central nervous system from deleterious eff ects of noxious stimuli and resulting allodynia, and increased pain. Gabapentin and pregabalin have antiallodynic and antihyperalgesic properties useful for treating neuro pathic pain and may also be benefi cial in acute postop erative pain. [15] [16] [17] [18] In some of the studies conducted with pregabalin as preemptive analgesic, like minor gynecological surgery involving the uterus by Peach et al. [19] in 2007, day-case gynecological laparoscopic surgery by 2008 Jokela et al., [20] and laparoscopic cholecystectomy by Agarwal et al., [21] a single dose of 100-150 mg was used. The present study was diff erent from these studies in the analgesic eff ect of pregabalin. The pain scores in the placebo group of the earlier studies mentioned were substantially low and the dose of pregabalin in the present study would have been subtherapeutic as laminectomy, discectomy, and instrumentation are much more painful procedures. Therefore, the present study used a single preemptive 300 mg dose of pregabalin. The duration after operation when rescue analgesic was required was 15.38 ± 3.52 h in the case of pregabalin and 9.41 ± 1.84 h in the case of gabapentin, which was statistically and signifi cantly lower in the case of gabapentin. Subsequent dose required in the case of pregabalin was 6.45% and in the case of gabapentin was 9.68%.
In a study conducted by Saraswat et al., [14] time to rescue analgesic was 8.98 ± 5.38 h for the gabapentin group, which was signifi cantly less (P value <0.001) than the pregabalin group (14.17 ± 6.67 h), whereas the total dose of rescue analgesic (mg) in the 24-h postoperative period was 62.5 ± 28.43 mg for pregabalin, being lower than 5 ± 23.99 mg for gabapentin, and was statistically not signifi cant between the groups.
The requirement of subsequent number of rescue analgesic doses in the 24 h of postoperative period between the groups have shown that in Group G (gabapentin group) and Group P (pregabalin group), it was only for 3/0/0 and 2/0/0 (1 dose/2 doses/3 doses) patients, respectively. This fi nding is in agreement with the results of the study conducted by Saraswat et al. [14] where the number of doses in 24 h (0 dose/1 dose/2 doses) in the gabapentin group was 2/26/2 and for the pregabalin group was 4/25/1 (no discernible diff erence between the two groups).
Peach et al. [19] in 2007 conducted the study in 90 women having minor gynecological surgery involving the uterus. Patients received either oral pregabalin 100 mg or placebo approximately 1 h before surgery, whereas in our study 300 mg pregabalin was used in infraumblical surgery under spinal anesthesia. There was no signifi cant diff erence between the groups regarding pain experienced in the recovery room or thereafter or for recovery room fentanyl requirement (42% group pregabalin versus 27% group placebo, P value = 0.12) or the quality of recovery at 24 h postoperatively.
Agarwal et al. [21] in 2008 evaluated the effi cacy of a single preoperative dose of 150 mg pregabalin when given 1 h before surgery for attenuating postoperative pain and fentanyl consumption after laparoscopic cholecystectomy compared to the placebo. Our study in contrast used 300 mg dose of pregabalin and that too in infraumblical surgery. Postoperative pain (static and dynamic) was assessed by a 100 mm VAS and the subjects received patient-controlled IV fentanyl analgesia during the postoperative period while in our study only static scores were measured and diclofenac was used as rescue analgesic. Result of the study revealed that postoperative pain (static and dynamic) and postoperative patient-controlled fentanyl consumption were reduced in the pregabalin group compared with the placebo group (P < 0.05).
Sahu et al. in 2010 [22] conducted a study to evaluate the role of pregabalin in reducing postoperative pain and rescue analgesic demand in patients undergoing infraumbilical surgeries under spinal anesthesia. In Group I placebo capsules 12 h before surgery and 1 h before surgery and in Group II, pregabalin capsules (150 mg) 12 h before surgery and 1 h (150 mg) before surgery were used. After giving anesthesia, the patients were assessed every 2 h for 24 h for pain score by VAS scale, blood pressure (BP), pulse rate, respiratory rate, rescue analgesics demand (injection tramadol IV), and side eff ects if any. In our study, only one preemptive dose of 300 mg pregabalin or 1200 mg gabapentin was used instead of two doses at 12 h intervals. Postoperative respiratory rate was not seen in our study and rescue analgesic used was diclofenac. Patients in the pregabalin group had signifi cantly lower mean VAS postoperatively and lower rescue analgesic consumption than the placebo group (I) (P < 0.05), which were nearly similar to our results.
In studies by Saraswat et al. [14] patients in Group G were given a single dose of gabapentin 1,200 mg, whereas in Group P, the patients were administered pregabalin 300 mg 1 h prior to the administration of spinal anesthesia, which was similar to our study. Pain was assessed by VAS immediately after operation and every 2 h thereafter, time since spinal anesthesia to the fi rst dose of analgesic (diclofenac) and total dose of analgesic in the fi rst 24 h was recorded, similar to our study. The total postoperative analgesic time was 8.98 h in Group G, whereas 14.17 h in Group P (HS, P < 0.001) and total dose of analgesics in the fi rst 24 h was 62.5 mg in Group P and 72.5 mg in Group G and was not signifi cant (P > .05). In our study, total postoperative analgesic time was 9.41 ± 1.84 h in Group G, whereas it was 15.38 ± 3.52 h in Group P.
Gajraj [23] reviewed the phamacology of pregabalin and found that somnolence (29.2%) and dizziness (22.2%) were the most common side eff ects, which were similar to our study but the percentage incidence was much lower (12.90% and 9.68%).
The incidences of nausea and vomiting were not found in our study. Turan et al. [2] showed that the use of oral gabapentin given preoperatively in patients of spinal surgery showed a signifi cant reduction in the incidence of vomiting (P < 0.05) compared to the placebo. No incidence of nausea/vomiting in the gabapentin and pregabalin groups in our study might be attributed to the fact that very little rescue analgesic was required in these groups. Another cause might be the antiemetic action of gabapentinoids that has already been established.
Peach et al. [19] in 2007 conducted a study in 90 women having minor gynecological surgery involving the uterus. Patients received either oral pregabalin 100 mg or placebo approximately 1 h before surgery, whereas in our study 300 mg pregabalin was used in infraumblical surgery under spinal anesthesia. In their study, incidences of posthospital discharge lightheadedness, visual disturbance, and diffi culty with walking were signifi cantly higher in the pregabalin group but in our study, somnolence and dizziness were signifi cantly less than the gabapentin group.
In 2008 Jokela et al. [24] conducted a study to evaluate the control of pain after perioperative administration of pregabalin 300 or 600 mg, compared with diazepam 10 mg in patients undergoing laparoscopic hysterectomy. In contrast, our study was on infraumblical surgery where only 300 mg pregabalin and no 600 mg dose was used; and gabapentin was used instead of diazepam. The incidences of dizziness (70% vs 35%; P = 0.012), blurred vision (63% vs 14%; P = 0.002), and headache (31% vs 7%; P = 0.041) were higher in the P600 group than in the D10 group.
Side eff ects such as somnolence (12.90%) and dizziness (9.68%) were signifi cantly less in the pregabalin group than the gabapentin group (somnolence: 22.59%, dizziness: 19.35%) in our study but not in the high magnitude as 70% (dizziness) and 63% (blurred vision) in their study. Thus, it may be said in conclusion that a 300 mg dose is better suited than 600 mg as used in their study to reduce the incidence of side eff ects.
Agarwal et al. [21] evaluated the efficacy of a single preoperative dose of 150 mg pregabalin when given 1 h before surgery for attenuating postoperative pain and fentanyl consumption after laparoscopic cholecystectomy compared to placebo. Ours in contrast used 300 mg dose of pregabalin and that too in infraumblical surgery. Side eff ects were similar in both the groups in their study but in ours, side eff ects were less in the pregabalin group.
Sahu et al. [22] evaluated the role of pregabalin in reducing postoperative pain and rescue analgesic demand in patients undergoing infra umbilical surgeries under spinal anesthesia. 300 mg of pregabalin was associated with less side eff ects in this study, which was similar to our study.
Conclusion
In conclusion, a single oral dose of pregabalin (300 mg) given preoperatively provides better postoperative pain control and decreases postoperative rescue analgesic consumption compared to a single dose of gabapentin (1,200 mg) . So it can be postulated that pregabalin may eff ectively be used as a part of the multimodal analgesic approach to prevent acute postoperative pain, much like gabapentin, which already has an established role.
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